Orca Bio
Raymond C. is an accomplished investor with extensive experience in the technology sector, particularly in Web3, cybersecurity, and healthcare. Currently serving as a Series A investor at Caldera and Stellar Cyber, Raymond also holds multiple seed investor roles at companies like ORA AI, BabylonChain Inc., and AKA Identity. Additionally, involvement with Yubico and Clipboard Health highlights a focus on innovative solutions in security and healthcare enrollment. As a managing partner at another venture capital firm, Raymond brings a background of entrepreneurship backed by esteemed firms like Kleiner Perkins. Educational qualifications include an MD from Stanford University School of Medicine, an MSc from the University of Oxford, and a BA in Chemistry from Case Western Reserve University.
This person is not in any teams
This person is not in any offices
Orca Bio
3 followers
Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Their manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling them to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Their talented team is driven by a passion for science and compassion for patients.